SEC Tracker
Get the app

Onconetix ONCO

Onconetix amends share exchange agreement

Merger communication

Form
425
Filed
Importance
Routine
  1. First Amendment to Share Exchange Agreement dated November 4, 2026
  2. Seller to own 95% of Buyer's shares if Net Cash less than $12.5M
  3. Net Cash definition includes Grid Promissory Note details
  4. End Date extended to March 31, 2027

Written from the 425 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Onconetix files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Enveric Biosciences ENVB public float $4M, Jun 30, 2025
  2. Polomar Health Services PMHS public float $4M, Jun 30, 2025
  3. Q/C Technologies QCLS public float $4M, Jun 30, 2025
  4. Integrated Biopharma INBP public float $3M, Dec 31, 2025
  5. Jaguar Health JAGX public float $4M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.